11
TÍTULO: EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
AUTORES: Hoes, JN; Jacobs, JWG; Boers, M; Boumpas, D; Buttgereit, F; Caeyers, N; Choy, EH; Cutolo, M; Da Silva, JAP; Esselens, G; Guillevin, L; Hafstrom, I; Kirwan, JR; Rovensky, J; Russell, A; Saag, KG; Svensson, B; Westhovens, R; Zeidler, H; Bijlsma, JWJ;
PUBLICAÇÃO: 2007, FONTE: ANNALS OF THE RHEUMATIC DISEASES, VOLUME: 66, NÚMERO: 12
INDEXADO EM: Scopus WOS CrossRef
12
TÍTULO: Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
AUTORES: Da Silva, JAP; Jacobs, JWG; Kirwan, JR; Boers, M; Saag, KG; Ines, LBS; de Koning, EJP; Buttgereit, F; Cutolo, M; Capell, H; Rau, R; Bijlsma, JWJ;
PUBLICAÇÃO: 2006, FONTE: ANNALS OF THE RHEUMATIC DISEASES, VOLUME: 65, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef
13
TÍTULO: Revisiting the toxicity of low-dose glucocorticoids - Risks and fears
AUTORES: Jost A P Da Silva; Johannes W G Jacobs; Johannes W J Bijlsma;
PUBLICAÇÃO: 2006, FONTE: 3rd International Conference on Neuroendocrine Immune Basis of the Rheumatic Diseases in BASIC AND CLINICAL ASPECTS OF NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES, VOLUME: 1069
INDEXADO EM: Scopus WOS
Página 2 de 2. Total de resultados: 13.